Non-ordinary states of consciousness (dreams, hypnosis, meditation, breath regulation) are a familiar aspect of psychotherapy. Recently, pharmaceutical psychedelics, such as MDMA, psilocybin, and ketamine, are being used in trials in the US and abroad to enhance psychotherapy for disorders such as PTSD, depression, and addictions. Understanding the common and divergent change processes in meditation practices, psychedelic treatment, and other methods of evoking non-ordinary states offers clinicians and researchers an opportunity to understand more deeply how psychological disorders are created and alleviated. This course will explore the history, science, neurobiology, ethical, and legal issues involved when working with non-ordinary states of consciousness, especially psychedelics.
Speakers/Topics include:
Hyatt Regency Boston 1 Ave de Lafayette Boston, MA 02111 United States